Issue 37

Cover story

Meeting the challenges of our age

Learn how the Faculty is tackling global challenges through initiatives focused on climate health, greener pharmaceutical design, harnessing artificial intelligence and data science in research and education, and enhancing opportunities for research translation and commercialisation.

Read more

On the EDGE of change

Discover how, under the visionary leadership of Professor Kirstie Galbraith and Associate Professor Steven Walker, the EDGE portfolio has been completely transformed to meet the needs of the 'pharmacist of the future'.

Beyond COVID: mRNA at MIPS

mRNA has become a growth area for the Faculty, encompassing several initiatives including VMIH, CORTx, mRNA Core and MMQPA, which are united by their emphasis on collaboration within and beyond Monash.

Teaching beyond the classroom

Learn how the Faculty’s Bachelor and Master of Pharmaceutical Science programs emphasise Monash’s commitment to student employment outcomes through professional placements and award-winning employability initiatives.

News in brief

Catch up on some of our faculty's biggest news stories from the past year.

  • Monash ranks #4 in the world

    for Pharmacy and Pharmacology in the 2025 QS World University Rankings by Subject.

    Read more

  • Professor Chris Porter

    appointed Sir John Monash Distinguished Professor.

    Read more

  • Monash University Malaysia’s School of Pharmacy

    marked their 15th anniversary with a grand celebration on 27 September 2024.

    Read more

  • Staff recognition and awards

    Learn more about those whose contributions were recognised this year.

    Read more

Research with impact

Here are some of the research stories that emerged over the past year.

How Australian scientists helped pave the way for a new class of medicines to treat schizophrenia

World first: Australian scientists uncover “plant-like” behaviour in important human cell regulator, opening up a new drug target for cancer, other diseases

Seaport Therapeutics secures US$225m Series B funding to develop neuropsychiatric medicines using Monash University prodrug technology

Australian researchers make breakthrough discovery on major global health threat: antibiotic resistance

New AI tool for rapid and cost-effective drug discovery

Scientists warn that greener drug design is urgently needed to address environmental pollution

Australian scientists develop a new method for the detection of Alzheimer’s

Study reveals deprescribing recommendations in clinical guidelines are falling short

New Medicines Manufacturing Innovation Centre opens: Monash accelerates medical innovation and development of life-saving treatments

Melbourne scientists reveal potential new therapy for organ damage caused by high blood pressure

Australia’s first mRNA vaccine candidate addresses COVID ‘immune imprinting’

Alchemy is produced by the Development Office, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University
Managing Editor: Rachel Ung · Writers: Emma Sorensen, Ralph Grayden, Karen Boalch, Karen Gee and Kate Carthew 
Photography: Ryan Wheatley, Kelli Morris · Research and distribution: Marian Simkin · Web: Anna Nguyen
Disclaimer: Views expressed in Alchemy are those of the authors and persons quoted and are not necessarily those of the Monash Faculty of Pharmacy and Pharmaceutical Sciences, Monash University.